Barclays Starts Foamix Pharmaceuticals (FOMX) at Overweight

October 13, 2014 6:43 AM EDT Send to a Friend
Barclays initiated coverage on Foamix Pharmaceuticals (NASDAQ: FOMX) with an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login